Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery Basic Research; Efficacy of hANP on lung cancer

Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery Basic Research; Efficacy of hANP on lung cancer - hANP study of lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004880

Enrollment

1000

Registered

2011-05-18

Start date

2007-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Group of hANP treatment Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients undergoing pulmonary resection for lung cancer in our hospital

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
1.The early reccurence of lung cancer after pulmonary resection 2.The incidence of postoperative complications after lung cancer surgery	—

Secondary

Measure	Time frame
1.Postoperative hemodynamics 2.Postoperative inflammatory change (white blood cell count and C-reactive protein level) 3.Postoperative creatinine levels and glomerular filtration rate	—

Countries

Japan

Contacts

Public ContactTakashi Nojiri

National Cerebral and Cardiovascular Center Biochemistry

nojiri@ri.ncvc.go.jp06-6833-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026